ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

10,209Medicare Part D Prescriptions Filled, Including Refills
$396K Total Retail Price of All Prescriptions
381 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 1,186 364 S3
CARISOPRODOL 372 49 R
TRAMADOL HCL 339 138
FUROSEMIDE 325 158
OMEPRAZOLE 274 94
PROMETHAZINE HCL 252 84 R
LISINOPRIL 252 95
GABAPENTIN 237 86
SINGULAIR 219 65
THEOPHYLLINE ANHYDROUS 207 68
ZOLPIDEM TARTRATE 196 104
POTASSIUM CHLORIDE 183 97
LEVOTHYROXINE SODIUM 182 112
HYDROCHLOROTHIAZIDE 177 104
NEXIUM 175 85
SIMVASTATIN 167 109
MELOXICAM 142 54
ATENOLOL 141 66
PROAIR HFA 140 64
CARVEDILOL 140 71
ACETAMINOPHEN-CODEINE 124 59 S3
METFORMIN HCL 119 58
PANTOPRAZOLE SODIUM 106 29
AMLODIPINE BESYLATE 103 53
BUSPIRONE HCL 102 57
METOPROLOL TARTRATE 97 48
RANITIDINE HCL 95 48
SPIRONOLACTONE 87 25
METHOCARBAMOL 81 23 R
CIPROFLOXACIN HCL 80 24
AMITRIPTYLINE HCL 74 21 R
PREDNISONE 67 46
PLAVIX 64 44
PREMARIN 63 18 R
SPIRIVA 62 22
LIDODERM 59 25
GEMFIBROZIL 59 25
IBUPROFEN 58 11
FLUOXETINE HCL 58 11
WARFARIN SODIUM 57 32
GLYBURIDE 57 33 R
CEPHALEXIN 56 24
SYMBICORT 55 13
LYRICA 52 0
PENTOXIFYLLINE 52 29
PHENYTOIN SODIUM EXTENDED 50 23
RAMIPRIL 50 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.